Business Development Manager, KACTUS
Multipass transmembrane proteins play central roles in essential biological processes such as cell signaling, intercellular communication, and cellular growth, making them some of the most attractive targets for therapeutic antibody discovery. However, producing these proteins in a soluble, functional form remains a major challenge, as their native structure depends on the presence of a lipid bilayer.
Recent advances in transmembrane protein display technologies now enable researchers to study these complex targets in their native conformation while preserving their biological activity. In this webinar, brought to you by KACTUS, Anil Kumar will explore the science behind these innovative platforms and demonstrate how they accelerate antibody discovery and the development of next-generation antibody therapeutics.
Topics to be covered in this webinar
- The science behind nanodisc and virus-like particle (VLP) display platforms for multipass transmembrane proteins
- How these platforms are used in antibody-based therapeutics research